StockData
Beta Bionics, Inc. logo

Beta Bionics, Inc. (BBNX) stock

BBNXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 11/304% below fair value
$14.72−0.49 (-3.22%)

Close on Nov 17, 2026Market cap $800.28MP/E –Yield –

Beta Bionics total assets

Total assets on the balance sheet at the end of each period.

Beta Bionics's total assets was $443.76M at Sep 30, 2026. For fiscal 2025 it was $328.74M, up 119.7% from the year before.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$328.74M+119.7%
FY2024Dec 31, 2024$149.65M+36.0%
FY2023Dec 31, 2023$110.04M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$443.76M+34.5%
Q2 FY2026Jun 30, 2026$292.39M-11.4%
Q1 FY2026Mar 31, 2026$304.42M-9.9%
Q4 FY2025Dec 31, 2025$328.74M+119.7%
Q3 FY2025Sep 30, 2025$330.05M+199.9%
Q2 FY2025Jun 30, 2025$329.97M–
Q1 FY2025Mar 31, 2025$338.02M–
Q4 FY2024Dec 31, 2024$149.65M–
Q4 FY2023Dec 31, 2023$110.04M–

More Beta Bionics figures

See a number that looks wrong?